Denne side blev automatisk oversat, og nøjagtigheden af ​​oversættelsen er ikke garanteret. Der henvises til engelsk version for en kildetekst.

Effekter af yoga på livskvaliteten for brystkræftpatienter

23. september 2026 opdateret af: Andreas Michalsen, Charite University, Berlin, Germany

Effects of Two Different Online Yoga Interventions on the Quality of Life of Breast Cancer Patients Compared With Waiting List - a Three-arm Randomized Controlled Trial

This study investigates the effects of two different online yoga interventions on the health-related quality of life in breast cancer patients. Qualitative and quantitative data will be collected.

Studieoversigt

Status

Rekruttering

Betingelser

Detaljeret beskrivelse

In this randomized controlled trial breast cancer patients will be randomized into three treatment arms:

  • Intervention group 1 will receive an Iyengar yoga intervention online in a group setting, based on the internationally renowned yoga school of B.K.S. Iyengar, which in the context of this study mainly includes physical and relaxation exercises.
  • Intervention group 2 will receive a meditative yoga intervention online including physical and meditation exercises and also ideologically neutral explanations of the ethical aspects of yoga.
  • Group 3 consists of a waiting list control group, combined with the offer to participate in a yoga intervention after 6 months.

Undersøgelsestype

Interventionel

Tilmelding (Anslået)

138

Fase

  • Ikke anvendelig

Kontakter og lokationer

Dette afsnit indeholder kontaktoplysninger for dem, der udfører undersøgelsen, og oplysninger om, hvor denne undersøgelse udføres.

Studiesteder

    • State of Berlin
      • Berlin, State of Berlin, Tyskland, 14109
        • Rekruttering
        • Charite University
        • Kontakt:
        • Ledende efterforsker:
          • Andreas Michalsen, Prof.Dr.

Deltagelseskriterier

Forskere leder efter personer, der passer til en bestemt beskrivelse, kaldet berettigelseskriterier. Nogle eksempler på disse kriterier er en persons generelle helbredstilstand eller tidligere behandlinger.

Berettigelseskriterier

Aldre berettiget til at studere

18 år til 75 år (Voksen, Ældre voksen)

Tager imod sunde frivillige

Ingen

Køn, der er berettiget til at studere

Kvinde

Beskrivelse

Inclusion Criteria:

  • Histologically confirmed diagnosis of non-metastatic breast cancer (TNM stage I-III) up to 5 years after diagnosis
  • Primary therapy completed for at least 3 months
  • Limitation of the quality of life due to the cancer (indication of at least 4 out of 10 points on the numerical analogue scale)
  • Willingness to participate in the study and signed informed consent.

Exclusion Criteria:

  • Current or planned chemotherapy, radiation or surgery
  • Severe physical or psychopharmacologically treated psychiatric comorbidity due to which a patient is unable to participate in the study
  • Pregnancy/breastfeeding
  • Participation in other clinical trials with behavioral, psychological, or complementary medicine interventions
  • Immobility or limitation for gymnastic exercise due to orthopedic, neurologic, or other medical cause
  • regular meditation practice >2x/month
  • regular yoga practice >2x/month

Studieplan

Dette afsnit indeholder detaljer om studieplanen, herunder hvordan undersøgelsen er designet, og hvad undersøgelsen måler.

Hvordan er undersøgelsen tilrettelagt?

Design detaljer

  • Primært formål: Støttende pleje
  • Tildeling: Randomiseret
  • Interventionel model: Parallel tildeling
  • Maskning: Ingen (Åben etiket)

Våben og indgreb

Deltagergruppe / Arm
Intervention / Behandling
Eksperimentel: Iyengar yoga

Intervention group 1 receives an Iyengar yoga intervention online in a group setting, based on the internationally renowned yoga school of B.K.S. Iyengar, which in the context of this study primarily includes physical and relaxation exercises.

Iyengar Yoga focuses on the correct alignment of the body while practicing the physical exercises of yoga. Props are used to support the body in finding the right alignment. Relaxation is also part of this intervention. Participiants receive 1x90 min guided yoga class per week for 8 weeks and are encouraged to continue their practice at home daily for at least 30 minutes.

Eksperimentel: Meditative yoga

Intervention group 2 receives an Integrative yoga intervention online including physical and meditation exercises as well as ideologically neutral explanations of the ethical aspects of Yoga.

Meditative Yoga in the context of this study means practicing the physical exercises of yoga as well as meditation. Additionally, each week one of the yamas/niyamas, which are ethical principles to live by in the Yoga philosophy, will be presented at the beginning of each class and will form the theme of the class. Participants receive 1x90 min guided yoga class per week for 8 weeks and are encouraged to continue their practice at home daily for at least 30 minutes.

Ingen indgriben: Waitlist Control Group

Group 3 consists of a waitlist control group. Participants will be offered the opportunity to attend a yoga intervention after 4 months. The patients in this waiting list control group are allowed to choose the yoga course after 6 months.

Hvad måler undersøgelsen?

Primære resultatmål

Resultatmål
Foranstaltningsbeskrivelse
Tidsramme
Functional Assessment of Cancer Therapy - Breast Cancer (FACT-B)
Tidsramme: Date of inclusion (baseline), after 8 weeks

Assessing full scale, range 0-40, higher score meaning a better outcome

Date of inclusion (baseline), after 8 weeks

Sekundære resultatmål

Resultatmål
Foranstaltningsbeskrivelse
Tidsramme
Functional Assessment of Cancer Therapy - Breast Cancer (FACT-B)
Tidsramme: Date of inclusion (baseline), after 8 weeks, after 16 weeks, after 24 weeks

Assessing full scale, range 0-40, higher score meaning a better outcome

Date of inclusion (baseline), after 8 weeks, after 16 weeks, after 24 weeks
Functional Assessment of Cancer Therapy: Fatigue (FACIT-F)
Tidsramme: Date of inclusion (baseline), after 8 weeks, after 16 weeks, after 24 weeks

Assessing full scale, range 0-52, higher score meaning a better outcom

Date of inclusion (baseline), after 8 weeks, after 16 weeks, after 24 weeks
Perceived Stress Scale (PSS-10)
Tidsramme: Date of inclusion (baseline), after 8 weeks, after 16 weeks, after 24 weeks

Assessing full scale, range 0-40, lower score meaning a better outcome

Date of inclusion (baseline), after 8 weeks, after 16 weeks, after 24 weeks
Flourishing Scale (FS-D)
Tidsramme: Date of inclusion (baseline), after 8 weeks, after 16 weeks, after 24 weeks

Assessing full scale, range 8-56, higher score meaning a better outcome

Date of inclusion (baseline), after 8 weeks, after 16 weeks, after 24 weeks
Self-Compassion Scale (SCS-D)
Tidsramme: Date of inclusion (baseline), after 8 weeks, after 16 weeks, after 24 weeks

Mean score of 12 items, range 1-5, higher score meaning a better outcome

Date of inclusion (baseline), after 8 weeks, after 16 weeks, after 24 weeks
Self-Efficacy Scale (ASKU)
Tidsramme: Date of inclusion (baseline), after 8 weeks, after 16 weeks, after 24 weeks

Mean score of 3 items, range 1-5, higher score meaning a better outcome

Date of inclusion (baseline), after 8 weeks, after 16 weeks, after 24 weeks
Sociodemographic measures
Tidsramme: Date of inclusion (baseline)

Age, education level, personal income, household income, employment status, job description, marital status, household members, days of sick leave past 3 months

Date of inclusion (baseline)
Behavioral questions: cigarettes
Tidsramme: Date of inclusion (baseline), after 8 weeks, after 16 weeks, after 24 weeks

Number of cigarettes on average per day in the last month

Date of inclusion (baseline), after 8 weeks, after 16 weeks, after 24 weeks
Behavioral questions: alcohol
Tidsramme: Date of inclusion (baseline), after 8 weeks, after 16 weeks, after 24 weeks

Number of alcoholic beverages on average per week in the last month

Date of inclusion (baseline), after 8 weeks, after 16 weeks, after 24 weeks
Expectation question
Tidsramme: Date of inclusion (baseline)

expectation of effectiveness of the intervention on a 5-point likert scale, how they expect to handle the intervention on a 5-point likert scale, higher score meaning better outcome

Date of inclusion (baseline)
Behavioural question
Tidsramme: Date of inclusion (baseline), after 8 weeks, after 16 weeks, after 24 weeks

diet

Date of inclusion (baseline), after 8 weeks, after 16 weeks, after 24 weeks
Behavioural question 2
Tidsramme: Date of inclusion (baseline)

Practice of other mindfulness practices besides Yoga

Date of inclusion (baseline)
Behavioural question 3
Tidsramme: Date of inclusion (baseline)

Yoga styles were practiced before

Date of inclusion (baseline)
Behavioural question 4
Tidsramme: Date of inclusion (baseline)

If and how often yoga is practiced regularly

Date of inclusion (baseline)
Functional Assessment of Cancer Therapy - General (FACT-G)
Tidsramme: Date of inclusion (baseline), after 8 weeks, after 16 weeks, after 24 weeks

Assessing full scale, range 0-108, higher score meaning a better outcome

Date of inclusion (baseline), after 8 weeks, after 16 weeks, after 24 weeks
Yama/Niyama Questionnaire - YaNiQ
Tidsramme: Date of inclusion (baseline), after 8 weeks, after 16 weeks, after 24 weeks

Assessing full scale, range 0-100, higher score meaning a better outcome

Date of inclusion (baseline), after 8 weeks, after 16 weeks, after 24 weeks
Hospital Anxiety and Depression Scale (HADS)
Tidsramme: Date of inclusion (baseline), after 8 weeks, after 16 weeks, after 24 weeks

Assessing full scale, range 0-42, lower score meaning a better outcome

Date of inclusion (baseline), after 8 weeks, after 16 weeks, after 24 weeks

Andre resultatmål

Resultatmål
Foranstaltningsbeskrivelse
Tidsramme
Qualitative interviews
Tidsramme: 8 weeks after inclusion

Qualitative assessment will be carried out in qualitative interviews in 20 patients participating in the study. The interviews will be recorded, transcribed and analyzed with qualitative content analysis.

8 weeks after inclusion
Heart Rate Variability (HRV)
Tidsramme: Date of inclusion (baseline), after 8 weeks

24h measuring by Faros 180

Date of inclusion (baseline), after 8 weeks

Samarbejdspartnere og efterforskere

Det er her, du vil finde personer og organisationer, der er involveret i denne undersøgelse.

Datoer for undersøgelser

Disse datoer sporer fremskridtene for indsendelser af undersøgelsesrekord og resumeresultater til ClinicalTrials.gov. Studieregistreringer og rapporterede resultater gennemgås af National Library of Medicine (NLM) for at sikre, at de opfylder specifikke kvalitetskontrolstandarder, før de offentliggøres på den offentlige hjemmeside.

Studer store datoer

Studiestart (Faktiske)

9. maj 2022

Primær færdiggørelse (Anslået)

1. april 2027

Studieafslutning (Anslået)

1. december 2027

Datoer for studieregistrering

Først indsendt

7. april 2022

Først indsendt, der opfyldte QC-kriterier

7. april 2022

Først opslået (Faktiske)

14. april 2022

Opdateringer af undersøgelsesjournaler

Sidste opdatering sendt (Faktiske)

25. september 2026

Sidste opdatering indsendt, der opfyldte kvalitetskontrolkriterier

23. september 2026

Sidst verificeret

1. september 2026

Mere information

Begreber relateret til denne undersøgelse

Nøgleord

Andre undersøgelses-id-numre

  • YOMA

Lægemiddel- og udstyrsoplysninger, undersøgelsesdokumenter

Studerer et amerikansk FDA-reguleret lægemiddelprodukt

Ingen

Studerer et amerikansk FDA-reguleret enhedsprodukt

Ingen

Disse oplysninger blev hentet direkte fra webstedet clinicaltrials.gov uden ændringer. Hvis du har nogen anmodninger om at ændre, fjerne eller opdatere dine undersøgelsesoplysninger, bedes du kontakte register@clinicaltrials.gov. Så snart en ændring er implementeret på clinicaltrials.gov, vil denne også blive opdateret automatisk på vores hjemmeside .

Abonner